Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caine P versus benzocaine for reducing palatal needle entry pain in children
IRCT20220412054516N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of benzocaine (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Needle entry pain before palatal anesthesia injection, Mean VAS after needle insertion in the benzocaine group and 2 more. Started May 2022; status: completed.
02
Drugs
benzocaine
Beyond the preview
Go deeper on IRCT20220412054516N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220412054516N1.